Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GLAXF) Return on Assets (2016 - 2025)

Historic Return on Assets for Gsk (GLAXF) over the last 17 years, with Q3 2025 value amounting to 0.17%.

  • Gsk's Return on Assets rose 400.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.14% for FY2022, which is 1200.0% up from last year.
  • Latest data reveals that Gsk reported Return on Assets of 0.17% as of Q3 2025, which was up 400.0% from 0.13% recorded in Q2 2025.
  • In the past 5 years, Gsk's Return on Assets registered a high of 0.25% during Q2 2023, and its lowest value of 0.02% during Q4 2021.
  • Over the past 5 years, Gsk's median Return on Assets value was 0.13% (recorded in 2025), while the average stood at 0.12%.
  • As far as peak fluctuations go, Gsk's Return on Assets tumbled by -1400bps in 2021, and later soared by 2200bps in 2023.
  • Quarter analysis of 5 years shows Gsk's Return on Assets stood at 0.02% in 2021, then skyrocketed by 841bps to 0.19% in 2022, then dropped by -3bps to 0.18% in 2023, then crashed by -38bps to 0.11% in 2024, then soared by 52bps to 0.17% in 2025.
  • Its Return on Assets stands at 0.17% for Q3 2025, versus 0.13% for Q2 2025 and 0.13% for Q1 2025.